Home
About
Publications Trends
Recent Publications
Expert Search
Archive
genetic factors
What Are Some Common Hereditary Cancer Syndromes?
Hereditary cancer syndromes are conditions where inherited genetic mutations significantly increase the risk of certain cancers. Some well-known syndromes include:
BRCA1 and BRCA2 mutations
: These increase the risk of breast and ovarian cancer.
Lynch syndrome
: Linked to colorectal, endometrial, and other cancers.
Familial adenomatous polyposis (FAP)
: Leads to colorectal cancer due to numerous polyps in the colon.
Li-Fraumeni syndrome
: Associated with a variety of cancers, including sarcomas and breast cancer.
Frequently asked queries:
What Are Genetic Factors in Cancer?
What Are Some Common Hereditary Cancer Syndromes?
Can Lifestyle Modifications Reduce Genetic Cancer Risk?
What Is the Future of Genetic Research in Cancer?
What are the Challenges in Cancer Metabolomics?
How Do Families Benefit?
What is Photothermal Therapy?
How Can Lifestyle Changes Help in Hearing Conservation?
How Can Technology Help Bridge the Gap in Cancer Care for Socioeconomic Groups?
How Successful is a Pancreaticoduodenectomy?
How Do Plastic Surgeons Work with Oncologists?
Is Aloe Vera Safe for Cancer Patients?
What is a Molar Pregnancy?
What Role Do Embedded Methods Play in Personalized Medicine?
What are the possible side effects of cancer treatments?
How Can Mood Changes Be Identified?
What are the Chances of Recurrence?
How to Handle Financial Pressure?
What are Cancer Health Disparities?
How Does PPA Work?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe